(주)엠엑스티 바이오텍에서 '연구개발 총괄' 포지션 인재를 #채용중입니다. 많은 관심과 지원 바랍니다 :) We're #Hiring! We're on the lookout for a 'Head of R&D'. If you're excited about leading our #Hydroporator development, we'd love to hear from you! #채용 #연구개발팀장 #유체천공기 #미세유체 #유전자전달 #유전자편집 #Recruitment #RnD #Microfluidics #GeneDelivery #Transfection #GenomeEditing
MxT Biotech
생명공학 연구
Developing transformative microfluidic platforms for cell engineering and immunotherapies
소개
MxT biotech, a Korea University spin-out, is a startup focused on developing transformative microfluidic gene delivery platforms for CGT developments.
- 웹사이트
-
https://www.mxtbiotech.com/
MxT Biotech 외부 링크
- 업계
- 생명공학 연구
- 회사 규모
- 직원 11-50명
- 본사
- Seoul
- 유형
- 비상장기업
- 설립
- 2021
위치
-
기본
길 보기
#907, Ttukseom-ro 17ga-gil 48, Seongdong-gu
KR Seoul 04785
MxT Biotech 직원
업데이트
-
Stop by booth 834 to discover more about Hydroporator® for your CGT developments at American Society of Gene & Cell Therapy conference! #Hydroporator MxT Biotech #asgct2024 #microfluidics #cgt #crispr
-
-
MxT Biotech is thrilled to unveil Hydroporator®, a groundbreaking gene delivery platform designed to expedite #CGT advancements at the #ASGCT2024. Don't miss out—visit booth #834 for further insights! Additionally, join us for the presentation of three posters (735, 736 & 738) on Wed, May 8th, at 12pm. See you there! #MxTBiotech #CGT #GeneDelivery
-
-
MxT Biotech님이 퍼감
20 Emerging BioTech Startups according to StartUs Insights Hera Biotech – Non-Surgical Endometriosis Diagnosis (USA) ATANIS Biotech AG – Functional Allergy Screening (Germany) Andson Biotech – Mass Spectrometry Workflow (USA) metaBIX Biotech – Pathogen Risk Detection (Uruguay) MxT Biotech – Microfluidic Gene Editing (South Korea) Entomal Biotech – Mobile Bio-Conversion System (Malaysia) Home Algae Biotechnology – Algae-derived Ingredients (Taiwan) Quantis Biotechnology– Human Bioidentical Proteins (Brazil) Aclid – Gene Synthesis Security Platform (USA) LatchBio – Cloud-based Bioinformatics Platform (USA) SUMATRIX BIOTECH – Biofabricated Materials (Turkey) PharmAla Biotech Inc. (MDMA.CSE) – Clinical Methylenedioxymethamphetamine (MDMA) (Canada) Glyphic Biotechnologies – Next-Generation Protein Sequencing (USA) RAGE Biotech – Chronic Inflammatory Diseases Treatment (Australia) HHV Biotech – Biofilm-related Therapeutics (Netherlands) Optieum Biotechnologies Inc. – Antibody-based Cancer Therapies (Japan) Gate2Brain – Therapeutic-Peptide Shuttles (Spain) Lumatix Biotech – Antibody Manufacturing (Germany) HydRegen – Sustainable Chemical Synthesis (UK) NewFish – Microalgae-based Superfoods (New Zealand) Original article: https://lnkd.in/eHuKQtiB #biotech #startup #technologyandinnovation 285/365
-
With #ASGCT2024 fast approaching, be sure to stop by booth #834 and discover MxT Biotech's innovative non-viral gene delivery platform, Hydroporator®, driving forward the progress of CGT development. Don't forget to save the date/time for our three posters on May 8th at 12pm! #MxTBiotech #CGT #GeneDelivery #ASGCT
-
-
We are thrilled to announce that MxT Biotech and CATUG have signed an MOU to form a strategic partnership!
We are excited to announce that MxT Biotech and CATUG have signed a Memorandum of Understanding to form a strategic partnership aimed at advancing research and development in the field of cell engineering. We are confident that CATUG’s expertise and know-how in nucleic acid and LNP technology in combination with MxT’s innovative non-viral gene delivery platform, Hydroporator®, will lead to significant contributions to the next generation of gene and cell therapy products. View the full press release ➡ https://lnkd.in/eXksZyJx #catug #biotechnology #genetherapy #celltherapy